Nanomedicine strategies to improve therapeutic agents for the prevention and treatment of preterm birth and future directions.
Journal
Nanoscale advances
ISSN: 2516-0230
Titre abrégé: Nanoscale Adv
Pays: England
ID NLM: 101738708
Informations de publication
Date de publication:
28 Mar 2023
28 Mar 2023
Historique:
received:
22
11
2022
accepted:
27
01
2023
medline:
1
4
2023
entrez:
31
3
2023
pubmed:
1
4
2023
Statut:
epublish
Résumé
The World Health Organisation (WHO) estimates 15 million babies worldwide are born preterm each year, with 1 million infant mortalities and long-term morbidity in survivors. Whilst the past 40 years have provided some understanding in the causes of preterm birth, along with development of a range of therapeutic options, notably prophylactic use of progesterone or uterine contraction suppressants (tocolytics), the number of preterm births continues to rise. Existing therapeutics used to control uterine contractions are restricted in their clinical use due to pharmacological drawbacks such as poor potency, transfer of drugs to the fetus across the placenta and maternal side effects from activity in other maternal systems. This review focuses on addressing the urgent need for the development of alternative therapeutic systems with improved efficacy and safety for the treatment of preterm birth. We discuss the application of nanomedicine as a viable opportunity to engineer pre-existing tocolytic agents and progestogens into nanoformulations, to improve their efficacy and address current drawbacks to their use. We review different nanomedicines including liposomes, lipid-based carriers, polymers and nanosuspensions highlighting where possible, where these technologies have already been exploited
Identifiants
pubmed: 36998665
doi: 10.1039/d2na00834c
pii: d2na00834c
pmc: PMC10044983
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1870-1889Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
SR is a Director of Tandem Nano Ltd and co-inventor of patents relating to drug delivery using nanotechnologies. SR has received research funding from GSK/ViiV, AZ and Gilead and a consultancy from Gilead. TM is a co-inventor of patents relating to drug delivery using nanotechnologies and has carried out consultancy work for Vifor Pharma.
Références
Pharmaceutics. 2022 Sep 23;14(10):
pubmed: 36297454
Nanomaterials (Basel). 2019 Mar 22;9(3):
pubmed: 30909401
J Comput Aided Mol Des. 2005 Jun;19(6):453-63
pubmed: 16231203
Indian J Pharm Sci. 2009 Jul;71(4):349-58
pubmed: 20502539
Int J Womens Health. 2014 Mar 27;6:343-9
pubmed: 24707187
Nat Rev Drug Discov. 2021 Feb;20(2):101-124
pubmed: 33277608
Pediatr Res. 2011 Aug;70(2):117-22
pubmed: 21505376
Ann Saudi Med. 2008 Jan-Feb;28(1):1-3
pubmed: 18299657
Drug Discov Today. 2018 Mar;23(3):534-547
pubmed: 29326082
Int J Nanomedicine. 2020 Aug 24;15:6295-6310
pubmed: 32943863
J Liposome Res. 2019 Dec;29(4):357-367
pubmed: 30526169
Pediatrics. 2007 Dec;120(6):1390-401
pubmed: 18055691
BMJ. 2012 Oct 09;345:e6226
pubmed: 23048010
Nanoscale Adv. 2020 Oct 19;2(12):5572-5577
pubmed: 36133871
Semin Perinatol. 2001 Oct;25(5):316-40
pubmed: 11707019
NPJ Genom Med. 2021 Jun 8;6(1):43
pubmed: 34103530
Front Pharmacol. 2015 Dec 01;6:286
pubmed: 26648870
Sci Transl Med. 2021 Jan 13;13(576):
pubmed: 33441428
Drug Discov Today Technol. 2004 Dec;1(4):337-41
pubmed: 24981612
Hong Kong Med J. 2008 Aug;14(4):267-72
pubmed: 18685158
ACS Nano. 2022 Apr 26;16(4):5246-5257
pubmed: 35293714
Pharmaceutics. 2022 Apr 15;14(4):
pubmed: 35456705
J Liposome Res. 2011 Jun;21(2):95-105
pubmed: 20429814
Drug Deliv Transl Res. 2020 Jun;10(3):766-790
pubmed: 32170656
Semin Perinatol. 2001 Oct;25(5):264-71
pubmed: 11707015
Eur J Pharm Biopharm. 2006 Jan;62(1):3-16
pubmed: 16129588
Int J Pharm Investig. 2014 Apr;4(2):60-4
pubmed: 25006550
Eur J Pharm Biopharm. 2016 Dec;109:224-235
pubmed: 27793755
Pharm Dev Technol. 2000;5(4):521-32
pubmed: 11109251
Pharmaceutics. 2018 May 18;10(2):
pubmed: 29783687
Taiwan J Obstet Gynecol. 2014 Dec;53(4):443-51
pubmed: 25510681
J Pharmacol Exp Ther. 2020 Jun;373(3):381-390
pubmed: 32205366
Am J Pathol. 2015 Mar;185(3):862-9
pubmed: 25579843
Pharmaceutics. 2019 Aug 08;11(8):
pubmed: 31398820
Colloids Surf B Biointerfaces. 2007 Nov 15;60(2):174-9
pubmed: 17656075
Mol Pharm. 2014 Mar 3;11(3):776-86
pubmed: 24484077
Lancet. 2012 Dec 15;380(9859):2095-128
pubmed: 23245604
Am J Obstet Gynecol. 2021 Jan;224(1):86.e1-86.e19
pubmed: 32598909
Eur J Pharm Biopharm. 2017 Oct;119:437-446
pubmed: 28760448
Lancet. 2021 Mar 27;397(10280):1183-1194
pubmed: 33773630
Int J Gynaecol Obstet. 2020 Jul;150(1):31-33
pubmed: 32524596
J Control Release. 2015 Feb 28;200:138-57
pubmed: 25545217
Pharmaceutics. 2017 Nov 20;9(4):
pubmed: 29156634
Mol Clin Oncol. 2014 Nov;2(6):904-908
pubmed: 25279172
J Nanobiotechnology. 2021 Oct 30;19(1):354
pubmed: 34717658
Lancet Glob Health. 2019 Jan;7(1):e37-e46
pubmed: 30389451
Cochrane Database Syst Rev. 2022 Aug 10;8:CD014978
pubmed: 35947046
Eur J Pharm Biopharm. 2000 Jul;50(1):161-77
pubmed: 10840199
Acta Biomater. 2018 Sep 15;78:247-259
pubmed: 30092376
Int J Nanomedicine. 2019 Mar 27;14:2191-2206
pubmed: 30988616
Obstet Gynaecol Reprod Med. 2010 Aug;20(8):241-247
pubmed: 24443652
Cochrane Database Syst Rev. 2013 Jul 31;(7):CD004947
pubmed: 23903965
Nucl Med Biol. 2009 Jul;36(5):515-24
pubmed: 19520292
Biomater Res. 2020 Jan 15;24:3
pubmed: 31969986
Ann Epidemiol. 1997 Aug;7(6):400-6
pubmed: 9279449
AAPS PharmSciTech. 2019 Feb 25;20(3):121
pubmed: 30805893
Int J Pharm. 2018 Apr 5;540(1-2):150-161
pubmed: 29438724
Lancet. 2016 May 21;387(10033):2106-2116
pubmed: 26921136
Hum Reprod. 2002 Dec;17(12):3060-4
pubmed: 12456603
Adv Drug Deliv Rev. 2008 May 22;60(8):939-54
pubmed: 18343527
Int J Womens Health. 2021 Aug 10;13:751-759
pubmed: 34408501
Bioact Mater. 2021 May 01;6(12):4402-4414
pubmed: 33997516
Biol Pharm Bull. 2009 Jul;32(7):1266-71
pubmed: 19571396
BMJ. 2022 Feb 15;376:e064547
pubmed: 35168930
N Engl J Med. 2003 Jun 12;348(24):2379-85
pubmed: 12802023
Fertil Steril. 2018 Feb;109(2):330-342.e9
pubmed: 29331236
Curr Opin Obstet Gynecol. 2004 Dec;16(6):459-63
pubmed: 15534440
RSC Adv. 2020 May 21;10(33):19521-19533
pubmed: 35515456
Molecules. 2018 Apr 14;23(4):
pubmed: 29662019
Fertil Steril. 2004 Jul;82(1):1-12
pubmed: 15236978
Pharmaceutics. 2019 Jul 14;11(7):
pubmed: 31337153
J Perinat Educ. 2005 Spring;14(2):26-35
pubmed: 17273430
Acta Pharm Sin B. 2019 Jan;9(1):4-18
pubmed: 30766774
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
BJOG. 2003 Apr;110 Suppl 20:98-102
pubmed: 12763122
Nat Nanotechnol. 2008 Aug;3(8):506-11
pubmed: 18685640
Adv Healthc Mater. 2014 Mar;3(3):400-11
pubmed: 23997027
J Mater Chem B. 2013 Sep 21;1(35):4455-4465
pubmed: 32261118
Cochrane Database Syst Rev. 2014 Jun 05;(6):CD002255
pubmed: 24901312
Obstet Gynaecol. 2018 Jan;20(1):57-63
pubmed: 30008614
BMJ Open. 2019 Nov 26;9(11):e029101
pubmed: 31772083
Sci Rep. 2016 Oct 11;6:34710
pubmed: 27725717
Ultrasound Obstet Gynecol. 2022 Feb;59(2):263-266
pubmed: 34941003
Front Chem. 2018 Aug 20;6:360
pubmed: 30177965
J Ocul Pharmacol Ther. 2013 Mar;29(2):216-28
pubmed: 23421502
Int J Nanomedicine. 2014 May 22;9:2539-55
pubmed: 24904213
Sci Transl Med. 2012 Jun 13;4(138):138ra79
pubmed: 22700955
AAPS PharmSciTech. 2019 Feb 27;20(3):129
pubmed: 30815765
Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004733
pubmed: 16034944
Sci Transl Med. 2012 Aug 29;4(149):149ra119
pubmed: 22932224
Nat Commun. 2016 Oct 21;7:13184
pubmed: 27767027
Am J Obstet Gynecol. 2017 Mar;216(3):283.e1-283.e14
pubmed: 27567564
Curr Pain Headache Rep. 2013 Apr;17(4):327
pubmed: 23423598
Singapore Med J. 2006 May;47(5):361-6
pubmed: 16645683
J Control Release. 2012 Jun 10;160(2):117-34
pubmed: 22484195
Angew Chem Int Ed Engl. 2008;47(50):9726-9
pubmed: 18979480
Am J Obstet Gynecol. 2013 Mar;208(3):194.e1-8
pubmed: 23433324
BJOG. 2006 Dec;113 Suppl 3:78-80
pubmed: 17206970
Nanomaterials (Basel). 2020 Jul 19;10(7):
pubmed: 32707641
Arch Dis Child Fetal Neonatal Ed. 2003 May;88(3):F199-202
pubmed: 12719392
Am J Obstet Gynecol. 2015 Apr;212(4):505.e1-13
pubmed: 25448524
Arch Dis Child Fetal Neonatal Ed. 2000 Sep;83(2):F79-85
pubmed: 10952696
J Mater Chem B. 2021 Dec 15;9(48):9874-9884
pubmed: 34870664
Am J Obstet Gynecol. 2015 Apr;212(4):508.e1-7
pubmed: 25683966
J Microencapsul. 2006 Jun;23(4):417-33
pubmed: 16854817
Arch Dis Child Fetal Neonatal Ed. 2004 Mar;89(2):F139-44
pubmed: 14977898
Int J Pharm. 2022 Jul 25;623:121862
pubmed: 35671851
Nanomedicine (Lond). 2019 Nov;14(21):2835-2851
pubmed: 31793846
Pharmaceuticals (Basel). 2013 May 23;6(6):689-99
pubmed: 24276256
J Drug Deliv. 2011;2011:591325
pubmed: 21490754
Nanomedicine. 2013 Feb;9(2):194-201
pubmed: 22687896
Nat Rev Drug Discov. 2004 Sep;3(9):785-96
pubmed: 15340388
J Control Release. 2017 Feb 28;248:71-95
pubmed: 28088572
Res Pharm Sci. 2018 Aug;13(4):288-303
pubmed: 30065762
Best Pract Res Clin Obstet Gynaecol. 2018 Oct;52:48-59
pubmed: 29724667
BMJ. 2009 Mar 05;338:b195
pubmed: 19264818
Obstet Gynecol Surv. 2019 Jan;74(1):50-55
pubmed: 30648727
Arch Gynecol Obstet. 2011 Oct;284(4):821-6
pubmed: 21072527
Ital J Pediatr. 2014 May 05;40:43
pubmed: 24887062
Nat Rev Drug Discov. 2015 Apr;14(4):239-47
pubmed: 25598505
Annu Rev Pharmacol Toxicol. 2023 Jan 20;63:471-489
pubmed: 36151050
Annu Rev Biomed Eng. 2012;14:1-16
pubmed: 22524388
Adv Drug Deliv Rev. 2021 Jul;174:190-209
pubmed: 33895215
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S585-S597
pubmed: 30306802
Cochrane Database Syst Rev. 2019 Nov 20;2019(11):
pubmed: 31745984
Chem Pharm Bull (Tokyo). 2014;62(5):399-406
pubmed: 24789922
Arch Dis Child Fetal Neonatal Ed. 2007 Mar;92(2):F88-93
pubmed: 17337673
Acta Pharm. 2012 Dec;62(4):433-72
pubmed: 23333884
J Control Release. 2019 Feb 10;295:74-86
pubmed: 30597245
Pediatrics. 1998 Nov;102(5):E56
pubmed: 9794986
Front Endocrinol (Lausanne). 2019 Feb 20;10:94
pubmed: 30842755
Nanoscale. 2021 Apr 7;13(13):6410-6416
pubmed: 33885522
Semin Fetal Neonatal Med. 2016 Apr;21(2):113-20
pubmed: 26795885
Am J Perinatol. 2020 Jan;37(2):127-136
pubmed: 31652479